News & Topics

May 22, 2013

Accelerating R&D thorugh joint research with a local institute
Establishment of R&D Center in Singapore

ARKRAY, Inc (headquarters: Kyoto City, Nakagyo Ward) has signed an agreement to begin joint research with a research institute in Singapore (IBN*1) under the umbrella of A-STAR (Singapore's Agency for Science, Technology and Research). The aim of this is to plan and develop products that grasp the needs of medicine throughout Asia and including the Middle East, and to accelerate the globalization and global standardization of R&D.

ARKRAY, Inc. (herein ARKRAY) has signed an agreement to begin joint research with a research institute (IBN) under the umbrella of Singapore’s Agency for Science, Technology and Research. This is ARKRAY’s first overseas R&D endeavour. With knowledge from our new research partner in Singapore, and ARKRAY’s business know-how and technology, we will cooperate from research all the way through to product development.

ARKRAY researchers will move out to IBN’s laboratory within Biopolis*2 and begin joint development. ARKRAY will make full use of the knowledge and experience of the excellent researchers IBN has drawn from around the world as well as the great research facilities and environment that Biopolis has to offer as we build on our global R&D functions. The joint development will begin with a focus on infectious disease testing- a field in high demand throughout Asia- and will work to build synergistic development projects and gradually expand our field of work.

ARKRAY is working to accelerate R&D to rapidly deliver new products that meet with global market needs and trends.

*1 IBN = Institute of Bioengineering and Nanotechnology
This is one organization under the umbrella of Singapore’s Agency for Science, Technology and Research (A-STAR) and specializes in the bio-engineering and nanotechnology fields. It is involved in research of advanced technology across many different medical fields.

*2 Biopolis
This is a cluster set up to around Singaporean Industry and public bio-medical research. To promote bio-medical research, it offers a range of infrastructure services such as lab equipment, diagnostic devices and meeting facilities required by bio research groups. 2000 researchers from 40 public and private research organizations are currently actively engaged in research there. Over the next four years, Biopolis’ aim is to become a bio-medical hub with 4,000 researchers.

We use (i) Necessary cookies to provide you with services on the website, (ii) Functional cookies to ensure the proper functioning of browsing, (iii) Analytical cookies to collect information to analyze the traffic to the website and (iv) Performance cookies to count visits and traffic sources in order to improve website performance.
You can inhibit Functional cookies and/or both Analytical and Performance cookies by clicking on OPTIONS.
By clicking ACCEPT, it will be deemed that you accept all the mentioned types of cookies.

When you visit our website, we use the following cookies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and accept/decline certain types of cookies that would otherwise be stored on your computer while browsing our website by adding/removing check marks. But keep in mind that deleting cookies may have an impact on your experience with our website.